Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Cancer. 2010 Apr 1;116(7):1767–1775. doi: 10.1002/cncr.24951

Figure 2. Changes in absolute lymphocyte count (ALC) with ipilimumab therapy.

Figure 2

(A) represents the ALC of all patients at baseline and after one and two ipilimumab doses while (B) represents the change in ALC for each patient with therapy.